The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)

Blood

Volumn 116, Issue 5, 2010, Pages 850-851

  Valent, Peter ^a   Arock, Michel ^b   Akin, Cem ^c   Sperr, Wolfgang R ^a   Reiter, Andreas ^d   Sotlar, Karl ^e   Hartmann, Karin ^f   George, Tracy I ^g   Brockow, Knut ^h   Kluin Nelemans, Hanneke C ⁱ   Gotlib, Jason ^g   Metcalfe, Dean D ^j   Horny, Hans Peter ^k  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Ecole Normale Superieure de Cachan   (France)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY OF COLOGNE   (Germany)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h TECHNICAL UNIVERSITY OF MUNICH   (Germany)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k Institute of Pathology Ansbach   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE CLASSIFICATION; HUMAN; LETTER; MAST CELL LEUKEMIA; MASTOCYTOSIS; MYELOID LEUKEMIA; MYOBLAST; PRIORITY JOURNAL; SYSTEMIC MASTOCYTOSIS; SYSTEMIC MASTOCYTOSIS WITH A CLONAL HEMATOLOGIC NON MAST CELL LINEAGE DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; CELL CLONE; CELL LINEAGE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLASSIFICATION; CONSENSUS; EUROPEAN UNION; GENETICS; HEMATOLOGIC DISEASE; MEDICAL SOCIETY; NOMENCLATURE; NOTE; PATHOLOGY; UNITED STATES; WORLD HEALTH ORGANIZATION;

STEM CELL FACTOR RECEPTOR;

CELL LINEAGE; CLONE CELLS; CONSENSUS; EUROPEAN UNION; HEMATOLOGIC DISEASES; HUMANS; LEUKEMIA, MAST-CELL; LEUKEMIA, MYELOID, ACUTE; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MASTOCYTOSIS, SYSTEMIC; PROTO-ONCOGENE PROTEINS C-KIT; SOCIETIES, MEDICAL; TERMINOLOGY AS TOPIC; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 77956280312     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-285270     Document Type: Letter

References (10)

1. Pardanani A, Tefferi A. Proposal for a revised classification of systemic mastocytosis. Blood. 2010;115(13):2720-2721.
2. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25(7):603-625.
3. Valent P, Akin C, Escribano L, et al. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 2007;37(6):435-453.
4. Valent P, Horny H-P, Li CY, et al. Mastocytosis. In Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Vol 1. Lyon, France: IARC Press; 2001:291-302.
5. Horny HP, Akin C, Metcalfe DD, et al. Mastocytosis (Mast cell disease). In Swerdlow, SH, Campo E, Harris NL, et al, eds. World Health Organization (WHO) Classification of Tumours. Pathology & Genetics. Tumours of Haematopoietic and Lymphoid Tissues. Vol 2. Lyon, France: IARC Press; 2008:54-63.
6. Horny HP, Sotlar K, Valent P. Mastocytosis: state of the art. Pathobiology. 2007; 74(2):121-132.
7. Horny HP, Sotlar K, Valent P. Differential diagnosis of systemic mastocytosis in routinely processed bone marrow biopsy specimens. Pathobiology. 2010, in press.
8. Sotlar K, Colak S, Bache A, et al. Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD). J Pathol. 2010;220(5):586-595.
9. Akin C, Scott LM, Kocabas CN, et al. Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood. 2007;110(7):2331-2333.
10. Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol. 2010; 125(6):1269-1278.e2.